| Predicting the need for third-line antiretroviral therapy by identifying patients at high risk for failing second-line antiretroviral therapy in South Africa D Onoya, C Nattey, E Budgell, L van den Berg, M Maskew, D Evans, ... AIDS patient care and STDs 31 (5), 205-212, 2017 | 41 | 2017 |
| HIV treatment outcomes among patients initiated on antiretroviral therapy pre and post-universal test and treat guidelines in South Africa K Hirasen, MP Fox, CJ Hendrickson, T Sineke, D Onoya Therapeutics and clinical risk management, 169-180, 2020 | 39 | 2020 |
| Post-TB health and wellbeing R Nightingale, F Carlin, J Meghji, K McMullen, D Evans, ... The International Journal of Tuberculosis and Lung Disease 27 (4), 248-283, 2023 | 38 | 2023 |
| Adverse drug reactions among patients initiating second-line antiretroviral therapy in South Africa D Onoya, K Hirasen, L van den Berg, J Miot, LC Long, MP Fox Drug Safety 41, 1343-1353, 2018 | 25 | 2018 |
| Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa D Evans, K Hirasen, R Berhanu, G Malete, P Ive, D Spencer, ... AIDS Research and Therapy 15, 1-12, 2018 | 24 | 2018 |
| Early outcomes of decentralized care for rifampicin-resistant tuberculosis in Johannesburg, South Africa: an observational cohort study R Berhanu, K Schnippel, E Mohr, K Hirasen, D Evans, S Rosen, I Sanne PloS one 11 (11), e0164974, 2016 | 24 | 2016 |
| The right combination–treatment outcomes among HIV-positive patients initiating first-line fixed-dose antiretroviral therapy in a public sector HIV clinic in Johannesburg … K Hirasen, D Evans, M Maskew, IM Sanne, K Shearer, C Govathson, ... Clinical epidemiology, 17-29, 2017 | 23 | 2017 |
| Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa C van Rensburg, R Berhanu, K Hirasen, D Evans, S Rosen, L Long PLoS One 14 (6), e0217820, 2019 | 18 | 2019 |
| High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa K Hirasen, R Berhanu, D Evans, S Rosen, I Sanne, L Long PLoS One 13 (10), e0205463, 2018 | 14 | 2018 |
| Low prevalence of depressive symptoms among stable patients on antiretroviral therapy in Johannesburg, South Africa K Shearer, D Evans, B Xhosa, K Hirasen, C Bracken, K Mahomed, L Long, ... Plos one 13 (9), e0203797, 2018 | 12 | 2018 |
| The household economic burden of drug-susceptible TB diagnosis and treatment in The Gambia I Devoid, AK Sillah, J Sutherland, O Owolabi, O Ivanova, C Govathson, ... The International Journal of Tuberculosis and Lung Disease 26 (12), 1162-1169, 2022 | 6 | 2022 |
| One pill, once a day: Simplified treatment regimens and retention in HIV care J Bor, SA Kluberg, MP LaValley, D Evans, K Hirasen, M Maskew, L Long, ... American Journal of Epidemiology 191 (6), 999-1008, 2022 | 2 | 2022 |
| Using a self-administered electronic adherence questionnaire to identify poor adherence amongst adolescents and young adults on first-line antiretroviral therapy in … K Hirasen, D Evans, N Jinga, R Grabe, J Turner, S Mashamaite, LC Long, ... Patient preference and adherence, 133-151, 2020 | 2 | 2020 |
| Uptake of same-day initiation of HIV treatment among adult men and women in Malawi, South Africa, and Zambia: the SPRINT retrospective cohort study A Huber, K Hirasen, AT Brennan, B Phiri, T Tcherini, L Mulenga, ... Gates Open Research 7 (42), 42, 2023 | 1 | 2023 |
| Uptake of same-day initiation of HIV treatment in Malawi, South Africa, and Zambia as reported in routinely collected data: the SPRINT retrospective cohort study A Huber, K Hirasen, AT Brennan, B Phiri, T Tcherini, L Mulenga, ... Gates Open Research 7, 2023 | 1 | 2023 |
| Multi-morbidities associated with tuberculosis in South Africa: a systematic review of the literature T Sineke, K Hirasen, M Loveday, L Long, D Evans Wits Journal of Clinical Medicine 4 (1), 32-46, 2022 | 1 | 2022 |
| Costs and outcomes of routine HIV oral pre-exposure prophylaxis implementation across different service delivery models and key populations in South Africa C Hendrickson, K Hirasen, C Mongwenyana, M Benade, R Bothma, ... medRxiv, 2023.08. 14.23294055, 2023 | | 2023 |
| Gates Open Research A Huber, K Hirasen, AT Brennan, B Phiri, T Tcherini, L Mulenga, ... | | 2023 |
| Uptake of same-day initiation of HIV treatment in Malawi, South Africa, and Zambia: the SPRINT retrospective cohort study A Huber, K Hirasen, AT Brennan, B Phiri, T Tchereni, L Mulenga, ... medRxiv, 2022.11. 28.22282854, 2022 | | 2022 |
